Your browser doesn't support javascript.
loading
Enhancing Efficiency and Reach Using Facebook to Recruit Breast Cancer Survivors for a Telephone-Based Supportive Care Randomized Trial During the COVID-19 Pandemic.
Ejem, Deborah B; Wechsler, Stephen; Gallups, Sarah; Khalidi, Sarah; Coffee-Dunning, Jazmine; Montgomery, Aoyjay P; Stevens, Courtney J; Keene, Kimberly; Rocque, Gabrielle B; Chamberlin, Mary; Hegel, Mark T; Azuero, Andres; Pisu, Maria; Ellis, Daphne; Ingram, Stacey A; Lawhon, Valerie M; Gilbert, Tiffany; Morrissette, Kali; Morency, Jamme; Thorp, Karen; Codini, Megan; Newman, Robin; Echols, Jennifer; Cloyd, Danielle; Dos Anjos, Sarah; Muse, Colleen; Goedeken, Susan; Laws, Kristen Elizabeth; Herbert, Jennae; Bakitas, Marie; Lyons, Kathleen D.
Afiliación
  • Ejem DB; School of Nursing, University of Alabama at Birmingham, Birmingham, AL.
  • Wechsler S; School of Health and Rehabilitation Sciences, Massachusetts General Hospital Institute of Health Professions, Boston, MA.
  • Gallups S; School of Nursing, University of Alabama at Birmingham, Birmingham, AL.
  • Khalidi S; School of Nursing, University of Alabama at Birmingham, Birmingham, AL.
  • Coffee-Dunning J; School of Nursing, University of Alabama at Birmingham, Birmingham, AL.
  • Montgomery AP; Department of Epidemiology, School of Public Health, University of Alabama at Birmingham, Birmingham, Al.
  • Stevens CJ; Department of Psychiatry, Dartmouth-Hitchcock Health, Lebanon, NH.
  • Keene K; Department of Radiation Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Rocque GB; Division of Geriatrics, Gerontology, and Palliative Care, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Chamberlin M; Divisions of Hematology & Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Hegel MT; Department of Hematology/Oncology, Dartmouth-Hitchcock Health, Lebanon, NH.
  • Azuero A; Department of Psychiatry, Dartmouth-Hitchcock Health, Lebanon, NH.
  • Pisu M; School of Nursing, University of Alabama at Birmingham, Birmingham, AL.
  • Ellis D; Division of Preventive Medicine, School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Ingram SA; O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL.
  • Lawhon VM; Department of Psychiatry, Dartmouth-Hitchcock Health, Lebanon, NH.
  • Gilbert T; Divisions of Hematology & Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Morrissette K; Divisions of Hematology & Oncology, Heersink School of Medicine, University of Alabama at Birmingham, Birmingham, AL.
  • Morency J; Department of Psychiatry, Dartmouth-Hitchcock Health, Lebanon, NH.
  • Thorp K; Department of Psychiatry, Dartmouth-Hitchcock Health, Lebanon, NH.
  • Codini M; Department of Rehabilitation Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
  • Newman R; Department of Rehabilitation Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
  • Echols J; Department of Rehabilitation Medicine, Dartmouth-Hitchcock Medical Center, Lebanon, NH.
  • Cloyd D; College of Health and Rehabilitation Sciences, Boston University, Boston, MA.
  • Dos Anjos S; School of Nursing, University of Alabama at Birmingham, Birmingham, AL.
  • Muse C; School of Nursing, University of Alabama at Birmingham, Birmingham, AL.
  • Goedeken S; School of Nursing, University of Alabama at Birmingham, Birmingham, AL.
  • Laws KE; Department of Occupational Therapy, School of Health Professions, University of Alabama at Birmingham, Birmingham, AL.
  • Herbert J; School of Health and Rehabilitation Sciences, Massachusetts General Hospital Institute of Health Professions, Boston, MA.
  • Bakitas M; Department of Occupational Therapy, Massachusetts General Hospital, Boston, MA.
  • Lyons KD; School of Health and Rehabilitation Sciences, Massachusetts General Hospital Institute of Health Professions, Boston, MA.
JCO Oncol Pract ; 19(11): 1020-1030, 2023 Nov.
Article en En | MEDLINE | ID: mdl-37733975
ABSTRACT

PURPOSE:

Evidence supporting social media-based recruitment of cancer survivors is limited. This paper describes how we used Facebook during the COVID-19 pandemic to augment our recruitment of breast cancer survivors for our two-site telephone-based randomized clinical trial (RCT) at Dartmouth-Hitchcock Medical Center and the University of Alabama at Birmingham.

METHODS:

Originally a two-site RCT of a telephone-delivered breast cancer survivorship intervention, we extended our clinic-based recruitment to Facebook. Participant characteristics, geographic reach, and baseline outcomes were compared across recruitment sources (ie, two clinics and Facebook) using descriptive statistics and effect sizes.

RESULTS:

Enrollment rates (20%-29%) were comparable across recruitment sources. The 21-month Facebook marketing campaign accounted for 59% (n = 179/303) of our total sample and had the greatest geographic reach, recruiting women from 24 states. The Facebook campaign reached a total of 51,787 unique individuals and cost $88.44 in US dollars (USD) per enrolled participant. Clinic samples had a greater proportion of women who were widowed (8% v 1%; P = .03) and Facebook had a higher proportion of women with a household income over $40,000 USD (83% v 71%; P = .02). There were no statistically significant differences between Facebook and the two clinics on baseline survey scores.

CONCLUSION:

Augmenting traditional recruitment with Facebook increased our RCT's geographic and sociodemographic reach and supported meeting recruitment goals in a timely way. In the wake of the COVID-19 pandemic, cancer survivorship researchers should consider using social media as a recruitment strategy while weighing the advantages and potential biases introduced through such strategies.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Medios de Comunicación Sociales / Supervivientes de Cáncer / COVID-19 Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: JCO Oncol Pract Año: 2023 Tipo del documento: Article País de afiliación: Albania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Mama / Medios de Comunicación Sociales / Supervivientes de Cáncer / COVID-19 Tipo de estudio: Clinical_trials Límite: Female / Humans Idioma: En Revista: JCO Oncol Pract Año: 2023 Tipo del documento: Article País de afiliación: Albania